Analyst firms · Citigroup · MDT

Citigroup MDT price target and rating history

Medtronic plc. (MDT) · Health Care

Citigroup rates Medtronic plc. (MDT) Buy with a $117 price target, as of its latest action on Feb 3, 2026. It has published 6 rating actions on MDT since August 2021, including 1 upgrade and 1 downgrade. Across 7 firms with a MDT price target in the last 12 months, the median target is $100. Citigroup's $117 is 17% above that.

Current rating
Buy
Price target
$117
Median target, all firms
$100
Actions on MDT
6

Citigroup price target on MDT

$153$119$8520222023202420252026
Citigroup price target on MDT, each point a stated target, August 2021 to February 2026.

Every Citigroup rating on MDT

How other firms rate MDT

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BarclaysEqual Weight$95Oct 7, 2026
NeedhamBuy$114Aug 27, 2026
UBSBuy$100Jul 28, 2026
BTIGBuy$90Jun 4, 2026
Goldman SachsNeutral$84May 21, 2026
CitigroupBuy$117Feb 3, 2026
Wells FargoOverweight$114Jan 30, 2026
William BlairOutperformJan 6, 2026

Questions about Citigroup and MDT

What is Citigroup's price target for MDT?
Citigroup's latest stated price target for Medtronic plc. (MDT) is $117, from its action on Feb 3, 2026.
What is Citigroup's rating on MDT?
Citigroup rates MDT Buy, a bullish rating, as of Feb 3, 2026.
When did Citigroup last change its view on MDT?
On Feb 3, 2026, Citigroup resumes coverage at Buy, price target $117.
How does Citigroup's MDT target compare with other analysts?
Across 7 firms with a MDT price target in the last 12 months, the median target is $100. Citigroup's $117 is 17% above that.

More MDT rating histories

All Citigroup ratingsMDT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.